These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

192 related articles for article (PubMed ID: 29570044)

  • 1. Alteplase for the treatment of acute ischemic stroke in patients with low National Institutes of Health Stroke Scale and not clearly disabling deficits (Potential of rtPA for Ischemic Strokes with Mild Symptoms PRISMS): Rationale and design.
    Yeatts SD; Broderick JP; Chatterjee A; Jauch EC; Levine SR; Romano JG; Saver JL; Vagal A; Purdon B; Devenport J; Khatri P
    Int J Stroke; 2018 Aug; 13(6):654-661. PubMed ID: 29570044
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effect of Alteplase vs Aspirin on Functional Outcome for Patients With Acute Ischemic Stroke and Minor Nondisabling Neurologic Deficits: The PRISMS Randomized Clinical Trial.
    Khatri P; Kleindorfer DO; Devlin T; Sawyer RN; Starr M; Mejilla J; Broderick J; Chatterjee A; Jauch EC; Levine SR; Romano JG; Saver JL; Vagal A; Purdon B; Devenport J; Pavlov A; Yeatts SD;
    JAMA; 2018 Jul; 320(2):156-166. PubMed ID: 29998337
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Antiplatelet vs. R-tPA for acute mild ischemic stroke: A prospective, random, and open label multi-center study.
    Wang XH; Tao L; Zhou ZH; Li XQ; Chen HS
    Int J Stroke; 2019 Aug; 14(6):658-663. PubMed ID: 30907301
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Tenecteplase versus alteplase for stroke thrombolysis evaluation (TASTE): A multicentre, prospective, randomized, open-label, blinded-endpoint, controlled phase III non-inferiority trial protocol.
    Bivard A; Garcia-Esperon C; Churilov L; Spratt N; Russell M; Campbell BC; Choi P; Kleinig T; Ma H; Markus H; Molina C; Hsu C; Tsai CH; Meretoja A; Strbian D; Butcher K; Wu T; Davis S; Donnan G; Levi C; Parsons M
    Int J Stroke; 2023 Jul; 18(6):751-756. PubMed ID: 36655938
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The multiarm optimization of stroke thrombolysis phase 3 acute stroke randomized clinical trial: Rationale and methods.
    Deeds SI; Barreto A; Elm J; Derdeyn CP; Berry S; Khatri P; Moy C; Janis S; Broderick J; Grotta J; Adeoye O
    Int J Stroke; 2021 Oct; 16(7):873-880. PubMed ID: 33297893
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Dual Antiplatelet Therapy vs Alteplase for Patients With Minor Nondisabling Acute Ischemic Stroke: The ARAMIS Randomized Clinical Trial.
    Chen HS; Cui Y; Zhou ZH; Zhang H; Wang LX; Wang WZ; Shen LY; Guo LY; Wang EQ; Wang RX; Han J; Dong YL; Li J; Lin YZ; Yang QC; Zhang L; Li JY; Wang J; Xia L; Ma GB; Lu J; Jiang CH; Huang SM; Wan LS; Piao XY; Li Z; Li YS; Yang KH; Wang DL; Nguyen TN;
    JAMA; 2023 Jun; 329(24):2135-2144. PubMed ID: 37367978
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Recombinant tissue-type plasminogen activator (Alteplase) for ischemic stroke 3 to 5 hours after symptom onset. The ATLANTIS Study: a randomized controlled trial. Alteplase Thrombolysis for Acute Noninterventional Therapy in Ischemic Stroke.
    Clark WM; Wissman S; Albers GW; Jhamandas JH; Madden KP; Hamilton S
    JAMA; 1999 Dec; 282(21):2019-26. PubMed ID: 10591384
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Clinical Course of Acute Ischemic Stroke Due to Medium Vessel Occlusion With and Without Intravenous Alteplase Treatment.
    Ospel JM; Menon BK; Demchuk AM; Almekhlafi MA; Kashani N; Mayank A; Fainardi E; Rubiera M; Khaw A; Shankar JJ; Dowlatshahi D; Puig J; Sohn SI; Ahn SH; Poppe A; Calleja A; Hill MD; Goyal M
    Stroke; 2020 Nov; 51(11):3232-3240. PubMed ID: 33070714
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effect of Argatroban Plus Intravenous Alteplase vs Intravenous Alteplase Alone on Neurologic Function in Patients With Acute Ischemic Stroke: The ARAIS Randomized Clinical Trial.
    Chen HS; Cui Y; Zhou ZH; Dai YJ; Li GH; Peng ZL; Zhang Y; Liu XD; Yuan ZM; Jiang CH; Yang QC; Duan YJ; Ma GB; Zhao LW; Wang RX; Sun YL; Shen L; Wang EQ; Wang LH; Feng YF; Wang FY; Zou RL; Yang HP; Wang K; Wang DL; Wang YL;
    JAMA; 2023 Feb; 329(8):640-650. PubMed ID: 36757755
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The rtPA (alteplase) 0- to 6-hour acute stroke trial, part A (A0276g) : results of a double-blind, placebo-controlled, multicenter study. Thromblytic therapy in acute ischemic stroke study investigators.
    Clark WM; Albers GW; Madden KP; Hamilton S
    Stroke; 2000 Apr; 31(4):811-6. PubMed ID: 10753980
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Radiographic Characteristics of Mild Ischemic Stroke Patients With Visible Intracranial Occlusion: The INTERRSeCT Study.
    Lau HL; Gardener H; Coutts SB; Saini V; Field TS; Dowlatshahi D; Smith EE; Hill MD; Romano JG; Demchuk AM; Menon BK; Asdaghi N
    Stroke; 2022 Mar; 53(3):913-920. PubMed ID: 34753303
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Thrombolysis for acute ischaemic stroke with alteplase in an Asian population: results of the multicenter, multinational Safe Implementation of Thrombolysis in Stroke-Non-European Union World (SITS-NEW).
    Rha JH; Shrivastava VP; Wang Y; Lee KE; Ahmed N; Bluhmki E; Hermansson K; Wahlgren N;
    Int J Stroke; 2014 Oct; 9 Suppl A100():93-101. PubMed ID: 22988894
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Safety and Efficacy of Intravenous Low-Dose Alteplase in Relative Contraindication Patients with Acute Ischemic Stroke.
    Ohta T; Okada K; Fukuda M; Masahira N; Matsuoka T; Tsuno T; Takemura M
    J Stroke Cerebrovasc Dis; 2018 Jul; 27(7):1844-1851. PubMed ID: 29555402
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A prospective, randomized, placebo-controlled, double-blind trial about safety and efficacy of combined treatment with alteplase (rt-PA) and Cerebrolysin in acute ischaemic hemispheric stroke.
    Lang W; Stadler CH; Poljakovic Z; Fleet D;
    Int J Stroke; 2013 Feb; 8(2):95-104. PubMed ID: 23009193
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Phase IIB/III trial of tenecteplase in acute ischemic stroke: results of a prematurely terminated randomized clinical trial.
    Haley EC; Thompson JL; Grotta JC; Lyden PD; Hemmen TG; Brown DL; Fanale C; Libman R; Kwiatkowski TG; Llinas RH; Levine SR; Johnston KC; Buchsbaum R; Levy G; Levin B;
    Stroke; 2010 Apr; 41(4):707-11. PubMed ID: 20185783
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Sex-based differences in response to recombinant tissue plasminogen activator in acute ischemic stroke: a pooled analysis of randomized clinical trials.
    Kent DM; Price LL; Ringleb P; Hill MD; Selker HP
    Stroke; 2005 Jan; 36(1):62-5. PubMed ID: 15569865
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Dual thrombolytic therapy with mutant pro-urokinase and small bolus alteplase for ischemic stroke (DUMAS): study protocol for a multicenter randomized controlled phase II trial.
    van der Ende NAM; Roozenbeek B; Smagge LEM; Luijten SPR; Aerden LAM; Kraayeveld P; van den Wijngaard IR; Lycklama À Nijeholt GJ; den Hertog HM; Flach HZ; Wallace AC; Gurewich V; Del Zoppo GJ; Meurer WJ; Lingsma HF; van der Lugt A; Dippel DWJ;
    Trials; 2022 Aug; 23(1):641. PubMed ID: 35945566
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Thrombolysis in Mild Stroke: A Comparative Analysis of the PRISMS and MaRISS Studies.
    Asdaghi N; Romano JG; Gardener H; Campo-Bustillo I; Purdon B; Khan YM; Gulati D; Broderick JP; Schwamm LH; Smith EE; Saver JL; Sacco R; Khatri P
    Stroke; 2021 Oct; 52(10):e586-e589. PubMed ID: 34496619
    [TBL] [Abstract][Full Text] [Related]  

  • 19. MRI-Guided Thrombolysis for Stroke with Unknown Time of Onset.
    Thomalla G; Simonsen CZ; Boutitie F; Andersen G; Berthezene Y; Cheng B; Cheripelli B; Cho TH; Fazekas F; Fiehler J; Ford I; Galinovic I; Gellissen S; Golsari A; Gregori J; Günther M; Guibernau J; Häusler KG; Hennerici M; Kemmling A; Marstrand J; Modrau B; Neeb L; Perez de la Ossa N; Puig J; Ringleb P; Roy P; Scheel E; Schonewille W; Serena J; Sunaert S; Villringer K; Wouters A; Thijs V; Ebinger M; Endres M; Fiebach JB; Lemmens R; Muir KW; Nighoghossian N; Pedraza S; Gerloff C;
    N Engl J Med; 2018 Aug; 379(7):611-622. PubMed ID: 29766770
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Functional Outcome of Intravenous Thrombolysis in Patients With Lacunar Infarcts in the WAKE-UP Trial.
    Barow E; Boutitie F; Cheng B; Cho TH; Ebinger M; Endres M; Fiebach JB; Fiehler J; Ford I; Galinovic I; Nickel A; Puig J; Roy P; Wouters A; Magnus T; Thijs V; Lemmens R; Muir KW; Nighoghossian N; Pedraza S; Simonsen CZ; Gerloff C; Thomalla G;
    JAMA Neurol; 2019 Jun; 76(6):641-649. PubMed ID: 30907934
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.